115 related articles for article (PubMed ID: 38293743)
1. Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis.
Wang L; Zhou J; Wang J; Wang X; Dong H; Zhao L; Wu J; Peng J
Adv Healthc Mater; 2024 May; 13(12):e2303710. PubMed ID: 38293743
[TBL] [Abstract][Full Text] [Related]
2. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
[TBL] [Abstract][Full Text] [Related]
3. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Sung YC; Liu YC; Chao PH; Chang CC; Jin PR; Lin TT; Lin JA; Cheng HT; Wang J; Lai CP; Chen LH; Wu AY; Ho TL; Chiang T; Gao DY; Duda DG; Chen Y
Theranostics; 2018; 8(4):894-905. PubMed ID: 29463989
[TBL] [Abstract][Full Text] [Related]
4. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
5. Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis.
Radwan SAA; El-Maadawy WH; ElMeshad AN; Shoukri RA; Yousry C
Pharm Res; 2020 Sep; 37(9):180. PubMed ID: 32875435
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
[TBL] [Abstract][Full Text] [Related]
7. Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis.
Hao Y; Song K; Tan X; Ren L; Guo X; Zhou C; Li H; Wen J; Meng Y; Lin M; Zhang Y; Huang H; Wang L; Zheng W
ACS Nano; 2022 Dec; 16(12):20739-20757. PubMed ID: 36454190
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
[TBL] [Abstract][Full Text] [Related]
9. Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy.
Shinn J; Park S; Lee S; Park N; Kim S; Hwang S; Moon JJ; Kwon Y; Lee Y
ACS Nano; 2024 Feb; 18(6):4704-4716. PubMed ID: 38288705
[TBL] [Abstract][Full Text] [Related]
10. Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.
Li S; Ren QJ; Xie CH; Cui Y; Xu LT; Wang YD; Li S; Liang XQ; Wen B; Liang MK; Zhao XF
World J Gastroenterol; 2024 Apr; 30(15):2143-2154. PubMed ID: 38681990
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.
Fan QQ; Zhang CL; Qiao JB; Cui PF; Xing L; Oh YK; Jiang HL
Biomaterials; 2020 Feb; 230():119616. PubMed ID: 31837823
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles.
Xiang L; Wang X; Jiao Q; Shao Y; Luo R; Zhang J; Zheng X; Zhou S; Chen Y
Acta Biomater; 2023 Sep; 168():497-514. PubMed ID: 37507035
[TBL] [Abstract][Full Text] [Related]
13. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
14. Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis.
Luo J; Zhang P; Zhao T; Jia M; Yin P; Li W; Zhang ZR; Fu Y; Gong T
ACS Nano; 2019 Apr; 13(4):3910-3923. PubMed ID: 30938986
[TBL] [Abstract][Full Text] [Related]
15. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury.
Sharma S; Ghufran SM; Das B; Roy B; Ghose S; Biswas S
Life Sci; 2021 Dec; 287():120119. PubMed ID: 34743004
[TBL] [Abstract][Full Text] [Related]
17. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
18. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1.
Lan T; Zhuang L; Li S; Yang G; Xuan Y; Guo J
Biomed Pharmacother; 2020 Oct; 130():110586. PubMed ID: 34321171
[TBL] [Abstract][Full Text] [Related]
19. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis：A study in vitro and in vivo.
Qin L; Qin J; Zhen X; Yang Q; Huang L
Biomed Pharmacother; 2018 May; 101():599-607. PubMed ID: 29518606
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
